3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
27
Lung Neoplasms
13
Carcinoma, Hepatocellular
8
Small Cell Lung Carcinoma
7
Cholangiocarcinoma
7
Neoplasms
6
Carcinoma
6
Urinary Bladder Neoplasms
5
Pancreatic Neoplasms
4
Neoplasm Metastasis
4
Biliary Tract Neoplasms
4
Triple Negative Breast Neoplasms
3
Neoplasms by Site
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Breast Neoplasms
3
Pathologic Complete Response
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasms by Histologic Type
2
Liver Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Bile Duct Neoplasms
2
Adenocarcinoma
2
Vaccinia
1
Unresectable Hepatocellular Carcinoma
1
Thoracic Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Interventions
Specimen Handling
4
Biopsy
4
Whole-Body Irradiation
3
Mycophenolic Acid
3
Cyclosporine
3
Cyclophosphamide
3
fludarabine phosphate
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Melphalan
2
Granulocyte Colony-Stimulating Factor
2
Busulfan
2
venetoclax
1
tocilizumab
1
ruxolitinib
1
peginterferon alfa-2b
1
iadademstat
1
fludarabine
1
Tacrolimus
1
Rituximab
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Idarubicin
1
Hyperbaric Oxygenation
1
Filgrastim
1
Etoposide
1
Cytarabine
1
Cyclosporins
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
durvalumab
×
30 days
×
Clear all
No trials found.